247 results
Page 3 of 13
8-K
EX-99.1
ggzpf5kxat7qdkvxkky3
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-99.1
ogqov3l
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.3
eujymtufms
1 Oct 20
Contingent Value Rights Agreement
8:42am
SC TO-T/A
EX-99
wqr5o76au627rl1ls91
30 Sep 20
Third party tender offer statement (amended)
8:06am
8-K
EX-10.4
v7p5hsqq
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
nwizi7
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
drtj5x vhv5xqzm1k1o6
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-99.1
20w y0a0mj
10 Aug 20
Information about tender offer
9:52pm
8-K
EX-99.1
g8ztipl31m
3 Aug 20
Ligand Reports Second Quarter 2020 Financial Results
7:48am
8-K
EX-99.1
0y5fu0pg5g2
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
tdx1od2x5crz0vl0
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
f1yc2eotqn w9b9cjrp
11 Feb 20
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen
4:28pm
8-K
EX-99.1
n2e690ls eklxr3p
6 Feb 20
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
EX-99.1
fkwsphwnkiy41jb3 1fa
5 Nov 19
Ligand Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-99.1
g4be277jb51fy61a4
30 Jul 19
Ligand Reports Second Quarter 2019 Financial Results
8:13am